{"transactions":[{"id":4638386,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-10-09T12:01:30.000Z","date":"2026-10-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":8.9,"value":44500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001445826-26-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020932/000144582626000014/primary_doc.xml","form_type":"4"}},{"id":4636865,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-10-07T12:57:36.000Z","date":"2026-10-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":8.7,"value":43500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001445826-26-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020932/000144582626000013/primary_doc.xml","form_type":"4"}},{"id":4636864,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-10-07T12:57:36.000Z","date":"2026-10-05","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":8.57,"value":42850.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001445826-26-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020932/000144582626000013/primary_doc.xml","form_type":"4"}},{"id":4636860,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":57297,"kind":"person","name":"Kemula Pierre Thadee Victor","position":1,"cik":"0002119332","reported_name":"Kemula Pierre Thadee Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2026-10-07T12:47:17.000Z","date":"2026-10-06","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":8.54,"value":17080.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0002119332-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2119332/000211933226000001/primary_doc.xml","form_type":"4"}},{"id":4636859,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":57297,"kind":"person","name":"Kemula Pierre Thadee Victor","position":1,"cik":"0002119332","reported_name":"Kemula Pierre Thadee Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2026-10-07T12:47:17.000Z","date":"2026-10-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":8.57,"value":42850.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0002119332-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2119332/000211933226000001/primary_doc.xml","form_type":"4"}},{"id":4636858,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":57297,"kind":"person","name":"Kemula Pierre Thadee Victor","position":1,"cik":"0002119332","reported_name":"Kemula Pierre Thadee Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2026-10-07T12:47:17.000Z","date":"2026-10-06","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":8.67,"value":26010.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0002119332-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2119332/000211933226000001/primary_doc.xml","form_type":"4"}},{"id":4636857,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":57302,"kind":"person","name":"Knotnerus Tim Jasper","position":1,"cik":"0002120886","reported_name":"Knotnerus Tim Jasper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common shares","published_at":"2026-10-07T12:06:35.000Z","date":"2026-10-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":8.7,"value":43500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":21823,"source":{"system":"sec-edgar","filing":"0002120886-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2120886/000212088626000001/primary_doc.xml","form_type":"4"}},{"id":4636856,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":57302,"kind":"person","name":"Knotnerus Tim Jasper","position":1,"cik":"0002120886","reported_name":"Knotnerus Tim Jasper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common shares","published_at":"2026-10-07T12:06:35.000Z","date":"2026-10-05","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":8.48,"value":50880.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."}],"balance_after":16823,"source":{"system":"sec-edgar","filing":"0002120886-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2120886/000212088626000001/primary_doc.xml","form_type":"4"}},{"id":4617837,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:06:59.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":57482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":57482,"derivative":{"exercise_price":13.94,"expiration_date":"2036-01-15","underlying":"Common shares","underlying_shares":57482},"source":{"system":"sec-edgar","filing":"0001104659-26-107916","document":"tm2625420-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020932/000110465926107916/tm2625420-4_4seq1.xml","form_type":"4"}},{"id":4617833,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:06:19.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":56328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":56328,"derivative":{"exercise_price":13.94,"expiration_date":"2036-01-15","underlying":"Common shares","underlying_shares":56328},"source":{"system":"sec-edgar","filing":"0001104659-26-107915","document":"tm2625420-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000110465926107915/tm2625420-3_4seq1.xml","form_type":"4"}}]}